According to Hikma Pharmaceuticals 's latest financial reports the company's current earnings are HK$2.87 Billion. In 2023 the company made an earning of HK$2.18 Billion, an increase over its 2022 earnings that were of HK$1.80 Billion. The earnings displayed on this page is the company's Pretax Income.